[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cogent Biosciences Inc 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 USA

www.cogentbio.com Employees: 258 P: 617-945-5576

Sector:

Medical

Description:

Cogent Biosciences Inc. is a biotechnology company. It is focused on developing precision therapies for genetically defined diseases. The company's program consist PLX9486. Cogent Biosciences Inc., formerly known as Unum Therapeutics Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 6,016,111
Enterprise Value, $K 6,016,391
Shares Outstanding, K 173,525
Float, K 162,090
% Float 93.41%
Short Interest, K 17,893
Short Float 10.31%
Days to Cover 10.52
Short Volume Ratio 0.55
% of Insider Shareholders 6.59%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -328,940 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -96,410 K
EBIT, $ -389,100 K
EBITDA, $ -387,900 K

Growth:

1-Year Return 187.00%
3-Year Return 167.10%
5-Year Return 320.75%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 86.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.52 on 08/10/26
Next Earnings Date 11/06/26
Earnings Per Share ttm -2.10
EPS Growth vs. Prev Qtr 1.89%
EPS Growth vs. Prev Year 1.89%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 11/09/20

COGT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -84.47%
Return-on-Assets % -47.72%
Profit Margin % 0.00%
Debt/Equity 0.42
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 13.55
Book Value/Share 3.12
Interest Coverage -106.50
60-Month Beta 0.38
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.